Videos
Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, discusses specialty areas experiencing innovative developments in therapies.
Thom Cohn, Chief Strategy Officer, Asembia, discusses special considerations for the launch of a personalized drug.
Pharmacy Week in Review: Policy Changes Can Improve Rural Health, Combo Therapy Investigated for AML
By
A look at last week's top stories in the world of pharmacy.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Apixaban vs Rivaroxaban: A Clearer Choice for VTE?
2
Craig Beavers, PharmD, Breaks Down the 2026 CKM Guidelines—And Why They Matter
3
Anticoagulation in AFib: Risk Stratification, Therapy Selection, and Factor XI Inhibitors
4
ADA 2026: Subcutaneous Furosemide May Reduce Heart Failure Hospitalizations in Patients With Diabetes
5